ICD-10-CM Billable Code

C71.7

Malignant neoplasm of brain stem

Clinical Classification Guidelines

Inclusion Terms

  • Malignant neoplasm of fourth cerebral ventricle
  • Infratentorial malignant neoplasm NOS

Medical Intelligence & Overview

Malignant neoplasm of the brain stem, classified under ICD-10 code C71.7, refers to a type of aggressive cancer that originates in the brain stem. The brain stem is a vital part of the brain located at the base near the spinal cord, responsible for controlling essential functions such as breathing, heartbeat, and consciousness. When a malignant tumor develops here, it can significantly impact these functions and poses serious health challenges. This condition may also be associated with tumors in the fourth cerebral ventricle or other infratentorial regions, although it primarily denotes malignancies originating or located in the brain stem area.

Causes & Symptoms

Clinical Causes: Genetic mutations that lead to abnormal cell growth Previous exposure to radiation or certain carcinogens Family history of brain tumors Rare environmental factors that may increase risk Potential hereditary syndromes linked to tumor development

Key Symptoms: Weakness or paralysis in limbs or face Loss of coordination and balance Difficulties with speech or swallowing Facial numbness or weakness Problems with vision, hearing, or sensation Altered consciousness or increased drowsiness Headaches that may worsen over time Dizziness or vertigo Difficulty with eye movements

Diagnostic & Treatment

Diagnosis Path: The diagnosis of a malignant brain stem tumor involves a combination of clinical evaluation and diagnostic tests, including: - Magnetic Resonance Imaging (MRI): This imaging technique provides detailed pictures of the brain and helps identify the precise location and size of the tumor. - Computed Tomography (CT) scan: Often used alongside MRI to assess the tumor's extent. - Biopsy: A tissue sample may be taken for histological examination to confirm malignancy. - Neurological exams: To evaluate the degree of functional impairment caused by the tumor. - Additional tests: Such as lumbar puncture or advanced imaging, may be performed to determine the spread or involvement of other areas.

Treatment Protocols: Treatment options for malignant neoplasm of the brain stem are complex due to the sensitive location of the tumor. They typically involve a multidisciplinary approach, which may include: - Surgery: To remove as much of the tumor as possible without damaging critical brain functions. - Radiation therapy: To target cancer cells and reduce tumor size. - Chemotherapy: Used to destroy cancer cells or slow their growth, often in combination with other treatments. - Targeted therapy or immunotherapy: Emerging options for specific tumor types that may provide additional benefits. - Supportive care: Including medications for symptom management, physical therapy, and palliative care to improve quality of life. - Participation in clinical trials: Patients may have access to new and experimental treatments under research studies.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C71.7 a billable ICD-10 code?
Yes, C71.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C71.7?
Clinical documentation must specify the nature of Malignant neoplasm of brain stem and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

brain neoplasm malignant